How can clinical trial units and networks help deliver high quality cancer trials

Are remissions for AML patients 'better' after daunorubicin and cytarabine liposome injection

Dasatinib vs imatinib in the treatment of paediatric ALL

Lenalidomide maintenance for transplant eligible and transplant ineligible newly diagnosed myeloma patients

PET-Directed therapy for early-stage diffuse large B-cell lymphoma

Is enasidenib plus azacitidine better than with azacitidine alone for AML patients?

Targeting CD70 with cusatuzumab eliminates acute myeloid leukaemia stem cells in humans

Outcomes in patients with therapy-Related AML who achieved remission with CPX-351 versus 7 plus 3: Phase 3 exploratory analysis

Clinical outcomes of patients with FLT3-ITD-mutated R/R AML undergoing HSCT after quizartinib or salvage chemo

Long-term outcomes of subjects with EBV driven PTLD following solid organ or allogeneic HCT treated with tabelecleucel

Prognostic impact of chromosomal abnormalities and copy number alterations in B-cell precursor ALL treated on UKALL14

Selective oestrogen receptor degraders as treatment for ER positive/HER2 negative advanced/metastatic breast cancer